JUL 17, 2023

Functional Characterization of Monoclonal Antibodies Using Kinetic Live-Cell Analysis

WRITTEN BY: Sarah Hoffman
Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have allowed drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies (mAbs) in treating cancers, chronic inflammation, and infectious diseases.

Click here to continue reading...